Skip to main content
. 2020 Jan 8;10(1):42–45. doi: 10.2991/jegh.k.191215.003

Table 1.

Second line drug resistance profile among rifampicin and isoniazid resistant isolates

Resistance type of isolates Total FQ R FQ S SLID R SLID S FQ and SLID both
Rifampicin resistant newly diagnosed 375 97 272 6 363 6
Rifampicin resistant follow-up 312 139 114 6 139 53
Isoniazid mono-resistant newly diagnosed 136 14 122 2 134 0
Isoniazid mono-resistant follow-up 40 15 25 3 37

FQ, fluoroquinolones; SLID, second line injectable drug; R, resistant; S, sensitive.